← SynDRA
U.18666A
SynDRA canonical compound SYN1970733 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Mechanism of action | oxidosqualene cyclase inhibitor |
Mechanisms of action (all sources)
- oxidosqualene cyclase inhibitor
Cross-references
Synonyms
- U-18666A
- U18666A
- 3beta-(2-Diethylaminoethoxy)androst-5-en-17-one hydrochloride
- U-18,666A
- NSC-70801
- V0DPR5J8ZJ
- (3S,8R,9S,10R,13S,14S)-3-[2-(diethylamino)ethoxy]-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one hydrochloride
- UNII-V0DPR5J8ZJ
- MFCD00210908
- 3-beta-(2-(Diethylamino)ethoxy)androst-5-en-17-one
- NCGC00181332-01
- U 18666A, powder
- C22H28Cl2N2.2HCl
- SCHEMBL4541550
- CHEMBL2354929
- DTXSID3046904
- CHEBI:190404
- (3S,8R,9S,10R,13S,14S)-3-(2-(diethylamino)ethoxy)-10,13-dimethyl-3,4,7,8,9,10,11,12,13,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17(2H)-one hydrochloride
- EX-A5264
- NSC70801
- Tox21_112792
- Androst-5-en-17-one, hydrochloride
- HB3543
- s9669
- AKOS024456717
- AC-36744
- CAS-3039-71-2
- HY-107433
- CS-0028465
- A937781
- Androst-5-en-17-one, hydrochloride, (3.beta.)-
- SR-01000946298
- SR-01000946298-1
- 3beta-(2-diethylaminoethoxy)androst-5-en-17-one HCl
- Q27291375
- 3-beta-2-Diethylaminoethoxyandrost-5-en-17-one hydrochloride
- (2R,3R)-2,3-O-(1-Phenylethylidene)-L-tartaricAcidDimethylEster
- (3?)-3-[2-(Diethylamino)ethoxy]androst-5-en-17-one hydrochloride
- (3b)-3-[2-(Diethylamino)ethoxy]androst-5-en-17-one hydrochloride
Look up U.18666A in the interactive SynDRA portal →